Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ke Zeng
Observed names:
K. Zeng,
Zeng Ke
Institutions:
University of North Carolina at Charlotte,
The University of Texas MD Anderson Cancer Center
Observed institutions:
University of North Carolina at Charlotte,
The University of Texas MD Anderson Cancer Center
ORCID:
0009-0009-1357-0444
Observed ORCID:
0009-0009-1357-0444
OpenAlex ID:
A5101513207
Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution
2018
·
Joshua N. Kellner
, Eveline M. Delemarre
, et al.
·
Oncotarget
·
49
PDF
Clinical Safety and Preliminary Efficacy of Regulatory T Cells for ALS
2025
·
Neil A. Shneider
, Alex V. Nesta
, et al.
·
NEJM Evidence
·
20
Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus
2023
·
Mi-Ae Lyu
, Ximing Tang
, et al.
·
Frontiers in Immunology
·
17
PDF
Phase 1 Study of CK0801 in Treatment of Bone Marrow Failure Syndromes
2024
·
Tapan M. Kadia
, Meixian Huang
, et al.
·
NEJM Evidence
·
15
Adjunct Therapy with T Regulatory Cells Decreases Inflammation and Preserves the Anti-Tumor Activity of CAR T Cells
2023
·
Ke Zeng
, Meixian Huang
, et al.
·
Cells
·
9
PDF
Effect of Routine Gastric Residual Aspiration on the Preterm Infant Fecal Microbiome
2022
·
Mary W. Lenfestey
, Nan Li
, et al.
·
American Journal of Perinatology
·
5
Phase I Clinical Trial of CK0801 (cord blood regulatory T cells) in Patients with Bone Marrow Failure Syndrome (BMF) Including Aplastic Anemia, Myelodysplasia and Myelofibrosis
2019
·
Tapan M. Kadia
, Hongbing Ma
, et al.
·
Blood
·
5
Adoptive Therapy with Allogeneic Cord Blood T Regulatory Cells Show Safety and Early Clinical Signal in Primary Myelofibrosis
2020
·
Tapan M. Kadia
, Naveen Pemmaraju
, et al.
·
Blood
·
3
Allogeneic Cord Blood Regulatory T Cells Can Prevent Graft Vs. Host Disease and Preserve Graft Vs Leukemia Effect: Update on Phase I/II Clinical Trial
2019
·
Ke Zeng
, Hongbing Ma
, et al.
·
Blood
·
3
Acute Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease Is Not Associated With Significant Differences in Gut Taxonomic Composition Compared to Steroid-Sensitive Gastrointestinal Graft-Versus-Host Disease Immediately Before Onset of Disease
2023
·
Ke Zeng
, Ryan Brewster
, et al.
·
Transplantation and Cellular Therapy
·
2
Adoptive Cord Blood T Regulatory Cell Therapy Leads to Resolution of Inflammation and Decreased Proteinuria in Lupus Nephritis
2020
·
Mi-Ae Lyu
, Joseph D. Khoury
, et al.
·
Blood
·
2
Single Injection of Cord Blood Regulatory T Cells Can Delay the Manifestations of Systemic Lupus Erythematosus
2019
·
Mi-Ae Lyu
, Joseph D. Khoury
, et al.
·
Blood
·
2
Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE
2025
·
Mi-Ae Lyu
, Ximing Tang
, et al.
·
Frontiers in Immunology
·
1
PDF
Duration of Hospitalization is Associated with the Gut Microbiome in Patients Undergoing Hematopoietic Stem Cell Transplantation: Early Results from a Randomized Trial of Home Versus Hospital Transplantation
2025
·
Tessa M. Andermann
, Ke Zeng
, et al.
·
OBM Transplantation
PDF
The impact of transplant location on the gut microbiome and resistome in patients undergoing hematopoietic stem cell transplantation at home versus in the hospital
2024
·
T.M. Andermann
, K. Zeng
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
A Phase Ib, Open-Label Study of Add on Therapy with CK0804 in Participants with Myelofibrosis and Suboptimal Response to Ruxolitinib
2023
·
Lucia Masarova
, Meixian Huang
, et al.
·
Blood
PDF
Phase Ib, open-label study of add on therapy with CK0804 in participants with myelofibrosis, with suboptimal response to ruxolitinib.
2023
·
Lucia Masarova
, Meixian Huang
, et al.
·
Journal of Clinical Oncology
Adoptive Therapy with Allogeneic Cord Blood T Regulatory Cells Improves Transfusion Requirement in Bone Marrow Failure Syndromes
2021
·
Tapan M. Kadia
, Naveen Pemmaraju
, et al.
·
Blood
Combination of Cord Blood T Regulatory Cells with Ruxolitinib Decreases Side Effects and Improves Survival in Xenogenic Graft Vs. Host Disease
2020
·
Ke Zeng
, Meixian Huang
, et al.
·
Blood
Show more works
View as search
Works count:
19
Citation count:
133
H-index:
5
I10-index:
4
Year
Topic
Type